Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
25 August 2019
| m 22:08 | Esophageal cancer (2 changes | history) . . (+1,211) . . [Jwarner (2×)] | ||
| m | 22:08 (cur | prev) . . (+31) . . Jwarner (talk | contribs) | ||
| m | 22:07 (cur | prev) . . (+1,180) . . Jwarner (talk | contribs) |
23 August 2019
22 August 2019
| 16:58 | Breast cancer (4 changes | history) . . (+7,487) . . [Jwarner (4×)] | ||
| m | 16:58 (cur | prev) . . (+2,666) . . Jwarner (talk | contribs) | ||
| 13:39 (cur | prev) . . (+2,541) . . Jwarner (talk | contribs) (→Cyclophosphamide monotherapy {{#subobject:fb7cyd|Regimen=1}}) | |||
| m | 13:25 (cur | prev) . . (+1,095) . . Jwarner (talk | contribs) (→Vinorelbine monotherapy {{#subobject:5c104c|Regimen=1}}) | ||
| 11:19 (cur | prev) . . (+1,185) . . Jwarner (talk | contribs) (→Paclitaxel & Bevacizumab {{#subobject:ab5252|Regimen=1}}) |
21 August 2019
| 19:37 | Esophageal cancer (3 changes | history) . . (+3,563) . . [Jwarner (3×)] | ||
| 19:37 (cur | prev) . . (+1,811) . . Jwarner (talk | contribs) (→Ramucirumab monotherapy {{#subobject:425b15|Regimen=1}}) | |||
| 19:34 (cur | prev) . . (+1,747) . . Jwarner (talk | contribs) (→Irinotecan & Mitomycin {{#subobject:dfc95f|Regimen=1}}) | |||
| m | 14:32 (cur | prev) . . (+5) . . Jwarner (talk | contribs) (→Chemotherapy) |
| m 14:33 | Diffuse large B-cell lymphoma (diff | hist) . . (+5) . . Jwarner (talk | contribs) |
| m 11:36 | Ovarian cancer (diff | hist) . . (-24) . . Jwarner (talk | contribs) (→Paclitaxel, nanoparticle albumin-bound monotherapy {{#subobject:3eae7f|Regimen=1}}) |
| m 11:30 | Breast cancer (diff | hist) . . (-499) . . Jwarner (talk | contribs) |
